Study to Evaluate Efficacy and Safety of HH2853 in Relapsed/Refractory Peripheral T-cell Lymphoma
Clinical trial NCT06909877 · RECRUITING
Trial details
- NCT number
- NCT06909877
- Sponsor
- Haihe Biopharma Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-27
- Primary completion
- 2025-10-31
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.